References
- Mahlangu J, Young G, Hermans C, et al. Defining extended half-life rFVIII-A critical review of the evidence. Haemophilia. 2018;24(3):348–358.
- Mahlangu JN, Blanchette V, Klamroth R. Redefining prophylaxis in the modern era. Haemophilia. 2021;27(Suppl 3):21–27.
- Skinner MW, Nugent D, Wilton P, et al. Achieving the unimaginable: health equity in haemophilia. Haemophilia. 2020;26(1):17–24.
- Weyand AC, James PD. Sexism in the management of bleeding disorders. Res Pract Thromb Haemost. 2021;5(1):51–54.
- Meijer K, van Heerde W, Gomez K. Diagnosis of rare bleeding disorders. Haemophilia. 2022;28(Suppl 4):119–124.
- Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357(6):535–544.
- Manco-Johnson MJ, Lundin B, Funk S, et al. Effect of late prophylaxis in hemophilia on joint status: a randomized trial. J Thromb Haemost. 2017;15(11):2115–2124.
- Warren BB, Thornhill D, Stein J, et al. Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the joint outcome continuation study. Blood Adv. 2020;4(11):2451–2459.
- Evatt BL. The tragic history of AIDS in the hemophilia population, 1982-1984. J Thromb Haemost. 2006;4(11):2295–2301.
- Farrugia A, Liumbruno GM, Candura F, et al. Factors affecting the quality, safety and marketing approval of clotting factor concentrates for haemophilia. Blood Transfus. 2018;16(6):525–534.
- Nugent D, Acharya SS, Baumann KJ, et al. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders. Expert Rev Hematol. 2023;16(S1):53–67. DOI: 10.1080/17474086.2023.2175661.
- Baldwin MK, Ahmadzia HK, Bartlett DL, et al. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research to advance the health of people with inherited bleeding disorders with the potential to menstruate. Expert Rev Hematol. 2023;16(S1):71–86. DOI: 10.1080/17474086.2023.2175660.
- Sidonio RF Jr., Bryant PC, Di Paola J, et al. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for mucocutaneous bleeding disorders. Expert Rev Hematol. 2023;16(S1):39–54. DOI: 10.1080/17474086.2023.2171983.
- Tran DQ, Benson CC, Boice JA, et al. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia. Expert Rev Hematol. 2023;16(S1):19–37. DOI: 10.1080/17474086.2023.2171981.
- Vázquez E, Kim M, Santaella ME. Lived Experience Experts: a name created by us for us. Expert Rev Hematol. 2023;16(S1):7–11. DOI: 10.1080/17474086.2023.2178410.
- Agency for Healthcare Research and Quality. An organizational guide to building health services research capacity [cited 2022 May 15]. Available from: https://www.ahrq.gov/funding/training-grants/hsrguide/hsrguide.html.
- Centers for Disease Control and Prevention. U.S. health disadvantage: causes and potential solutions U.S. health disadvantage: causes and potential solutions[cited 2023 Feb 14]. Available from: https://www.cdc.gov/policy/chep/health/index.html.
- U.S. Department of Health and Human Services. Community Health and Economic Prosperity: Engaging Businesses as Stewards and Stakeholders—A Report of the Surgeon General 2021 [cited 2023 Feb 14]. Available from: https://www.hhs.gov/sites/default/files/chep-sgr-full-report.pdf.
- Centers for Disease Control and Prevention. HTC population profile patient characteristics march 2022 - technical notes 2022 [cited 2022 Nov 4. Available from: https://www.cdc.gov/ncbddd/hemophilia/communitycounts/data-reports/2022-03/index.html.
- Valentino L, Baker J, Butler R, et al. Integrated hemophilia patient care via a national network of care centers in the United States: a model for rare coagulation disorders. J Blood Med. 2021;12:897–911.
- Centers for Disease Control and Prevention. Hemophila Treatment Centers [cited 2022 Aug 17]. Available from: https://www.cdc.gov/ncbddd/hemophilia/documents/a-simmons_htc-brochure-508c.pdf.
- Skinner MW, Soucie JM, McLaughlin K. The national haemophilia program standards, evaluation and oversight systems in the United States of America. Blood Transfus. 2014;12(Suppl 3):e542–8.23.
- Baker JR, Crudder SO, Riske B, et al. A model for a regional system of care to promote the health and well-being of people with rare chronic genetic disorders. Am J Public Health. 2005;95(11):1910–1916.
- Pai M, Key NS, Skinner M, et al. NHF-McMaster guideline on care models for haemophilia management. Haemophilia. 2016;22(Suppl 3):6–16.
- National Hemophilia Foundation Medical and Scientific Advisory Committee. MASAC Documents [cited 2022 Aug 17]. Available from: https://www.hemophilia.org/healthcare-professionals/guidelines-on-care/masac-documents
- National Hemophilia Foundation Medical and Scientific Advisory Committee. MASAC document 269- standards and criteria for the care of persons with congenital bleeding disorders [cited 2022 May 19. Available from: https://www.hemophilia.org/healthcare-professionals/guidelines-on-care/masac-documents/masac-document-269-standards-and-criteria-for-the-care-of-persons-with-congenital-bleeding-disorders.
- Srivastava A, Santagostino E, Dougall A, et al. WFH guidelines for the management of hemophilia, 3rd edition. Haemophilia. 2020;26(Suppl 6):1–158.
- Connell NT, Flood VH, Brignardello-Petersen R, et al. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. Blood Adv. 2021;5(1):301–325.
- James PD, Connell NT, Ameer B, et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv. 2021;5(1):280–300.
- American Thrombosis and Hemostasis Network. What We Do Overview [cited 2022 Jan 5. Available from: https://athn.org/what-we-do/overview.html.
- Riske B, Shearer R, Baker JR. Patient satisfaction with US hemophilia treatment center care, teams and services: the first national survey. Haemophilia. 2020;26(6):991–998.
- Butler RB, Cheadle A, Aschman DJ, et al. National needs assessment of patients treated at the United States federally-funded hemophilia treatment centers. Haemophilia. 2016;22(1):e11–7.
- National HTC Patient Satisfaction Survey. Third National Survey of US hemophilia treatment centers – over 5300 patients report on care obtained in 2020: national HTC patient satisfaction survey; 2022 [cited 2022 Aug 21]. Available from: https://www.htcsurvey.com/results.
- Baker JR, Riske B, Drake JH, et al. US hemophilia treatment center population trends 1990-2010: patient diagnoses, demographics, health services utilization. Haemophilia. 2013;19(1):21–26.
- Regling K, Callaghan MU, Sidonio R Jr. Managing severe hemophilia a in children: pharmacotherapeutic options. Pediatric Health Med Ther. 2022;13:27–35.
- Pierce GF. Uncertainty in an era of transformative therapy for haemophilia: addressing the unknowns. Haemophilia. 2021;27(Suppl 3):103–113.
- Arya S, Wilton P, Page D, et al. Healthcare provider perspectives on inequities in access to care for patients with inherited bleeding disorders. PLoS One. 2020;15(2):e0229099.
- Health Resources & Services Administration. 340B drug pricing program [cited 2022 Aug 18]. Available from: https://www.hrsa.gov/opa.
- Lopez K, Norris K, Hardy M, et al. Defining the Impact of social drivers on health outcomes for people with inherited bleeding disorders. J Clin Med. 2022;11:15.
- U.S. Department of Housing and Human Development (HUD). Diversity and inclusion definitions 2021 [cited 2023 Jan 30]. Available from: https://www.hud.gov/program_offices/administration/admabout/diversity_inclusion/definitions.
- George Washington University. Equity vs. equality: what’s the difference? 2020 [cited 2023 Jan 30]. Available from: https://onlinepublichealth.gwu.edu/resources/equity-vs-equality/.
- University of Toronto Division of the Vice President Research & Innovation. Equity, Diversity & Inclusion [cited 2022 Aug 18]. Available from: https://research.utoronto.ca/equity-diversity-inclusion/equity-diversity-inclusion.
- Braveman P, Arkin E, Orleans T, et al. What is health equity? And what difference does a definition make? Princeton, NJ: Robert Wood Johnson foundation; 2017. [cited 2023 Jan 31]. Available from: https://healthforward.org/wp-content/uploads/2017/11/rwjf-Health-Equity-Full-Report-437393.pdf.
- U.S. Department of health and human services office of disease prevention and health promotion. health equity in healthy people 2030 [cited 2022 Aug 18]. Available from: https://health.gov/healthypeople/priority-areas/health-equity-healthy-people-2030.
- Braveman P, Gruskin S. Defining equity in health. J Epidemiol Community Health. 2003;57(4):254–258.
- George Washington University. Diversity and inclusion defined [cited 2023 Jan 31]. Available from: https://diversity.gwu.edu/diversity-and-inclusion-defined.
- Bonilla-Silva E. Rethinking Racism: Toward a Structural Interpretation. Am Sociol Rev. 1997;62(3):465–480.
- James M, Burgos A. Race. in Stanford Encyclopedia of Philosophy 2020 [cited 2023 Jan 31]. Available from: https://plato.stanford.edu/entries/race/.
- Operario D, Fiske ST. Racism equals power plus prejudice: a social psychological equation for racial oppression. Confronting racism: the problem and the response. Thousand Oaks CA US: Sage Publications, Inc; 1998. p. 33–53.
- Schaefer RT. Racial and Ethnic Groups. 15th ed. New York (NY): Pearson; 2019.
- Came H, Griffith D. Tackling racism as a “wicked” public health problem: enabling allies in anti-racism praxis. Soc Sci Med. 2018;199:181–188.
- Ford CL, Airhihenbuwa CO. The public health critical race methodology: praxis for antiracism research. Soc Sci Med. 2010;71(8):1390–1398.
- Racism: Science and Tools for the Public Health Professional. Washington (DC): APHPA Press; 2019. [cited 2022 Aug 23]. Available from: https://ajph.aphapublications.org/doi/book/10.2105/9780875533049
- Bacong AM, Dillard AS, Bradford NJ. Appendix D: glossary. In: Ford CL, Griffith DM, Bruce MA, et al., editors. Racism: science & tools for the public health professional. Washington (DC): APHA Press; 2019. p. 519–543. [cited 2022 Aug 23]. Available from: https://ajph.aphapublications.org/doi/abs/10.2105/9780875533049appD
- Centers for Disease Control and Prevention. Social Determinants of Health at CDC [cited 2023 Jan 31]. Available from: https://www.cdc.gov/about/sdoh/index.html.
- World Health Organization. Social determinants of health 2021 [cited 2023 Jan 31]. Available from: https://www.who.int/teams/social-determinants-of-health#:~:text=The%20social%20determinants%20of%20health%20%28SDH%29%20are%20the,agendas%2C%20social%20norms%2C%20social%20policies%20and%20political%20systems.
- Artiga S, Hinton E. Beyond health care: the role of social determinants in promoting health and health equity 2018 [cited 2022 Aug 19]. Available from: https://www.kff.org/racial-equity-and-health-policy/issue-brief/beyond-health-care-the-role-of-social-determinants-in-promoting-health-and-health-equity/.
- The Community Guide Staff. Guide to community preventive services. advancing health equity 2022 [cited 2022 Oct 27]. Available from: https://www.thecommunityguide.org/pages/advancing-health-equity.html.
- U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion. Social Determinants of Health [cited 2022 Aug 19]. Available from: https://health.gov/healthypeople/priority-areas/social-determinants-health.
- Creary MS. Bounded justice and the limits of health equity. Journal of Law, Medicine & Ethics. 2021;49(2):241–256.
- Kuhlberg JA, Headen I, Ballard EA, et al. Advancing community engaged approaches to identifying structural drivers of racial bias in health diagnostic algorithms: data for black lives; 2020 [cited 2022 Aug 20]. Available from: https://www.filepicker.io/api/file/VC60nHDsSnOxtFXvnxw2.
- Weyand AC, Sidonio RF Jr., Sholzberg M. Health issues in women and girls affected by haemophilia with a focus on nomenclature, heavy menstrual bleeding, and musculoskeletal issues. Haemophilia. 2022;28(Suppl 4):18–25.
- van Galen KPM, d’Oiron R, James P, et al. A new hemophilia carrier nomenclature to define hemophilia in women and girls: communication from the SSC of the ISTH. J Thromb Haemost. 2021;19(8):1883–1887.
- Weyand AC, McGann PT. Eliminating race-based reference ranges in haematology: a call to action. Lancet Haematol. 2021;8(6):e462–e6.
- Krieger N. Refiguring “race”: epidemiology, racialized biology, and biological expressions of race relations. Int J Health Serv. 2000;30(1):211–216.
- Proctor EK, Landsverk J, Aarons G, et al. Implementation research in mental health services: an emerging science with conceptual, methodological, and training challenges. Adm Policy Ment Health. 2009;36(1):24–34.
- Eccles MP, Mittman BS. Welcome to Implementation Science. Implementation Sci. 2006;1(1):1–3.
- Loper A, Woo B, Metz A. Equity Is Fundamental to ImplementationScience 2021 [cited 2022 Aug 21]. Available from: https://ssir.org/articles/entry/equity_is_fundamental_to_implementation_science.
- Mouchantaf R, Auth D, Moride Y, et al. Risk management for the 21st century: current status and future needs. Drug Saf. 2021;44(4):409–419.
- Bolton-Maggs PH, Chalmers EA, Collins PW, et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol. 2006;135(5):603–633.
- Faughnan ME, Mager JJ, Hetts SW, et al. Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann Intern Med. 2020;173(12):989–1001.
- Gresele P. Subcommittee on platelet physiology of the international society on thrombosis andHemostasis. diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost. 2015;13(2):314–322.
- Kaufman RM, Djulbegovic B, Gernsheimer T, et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2015;162(3):205–213.
- Garrison LP, Kleinermans D. Is the world ready for gene therapy? Haemophilia. 2022;28(Suppl 2):5–8.
- Kaczmarek R. Gene therapy - are we ready now? Haemophilia. 2022;28(Suppl 4):35–43.
- Miesbach W, Chowdary P, Coppens M, et al. Delivery of AAV-based gene therapy through haemophilia centres-A need for re-evaluation of infrastructure and comprehensive care: a Joint publication of EAHAD and EHC. Haemophilia. 2021;27(6):967–973.
- Sidonio RF Jr., Pipe SW, Callaghan MU, et al. Discussing investigational AAV gene therapy with hemophilia patients: a guide. Blood Rev. 2021;47:100759.
- Curran GM, Bauer M, Mittman B, et al. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50(3):217–226.
- National Hemophilia Foundation. Mission & History [cited 2022 Jan 5]. Available from: https://www.hemophilia.org/who-we-are/our-story/mission-history.
- Rauch A, Valentino LA, Mills K, et al. Big picture initiatives in bleeding disorders. Haemophilia. 2022;28(Suppl 4):53–60.
- Valentino LA, Witkop ML, Santaella ME, et al. Building the blueprint: formulating a community-generated national plan for future research in inherited bleeding disorders. Haemophilia. 2022;28(5):760–768.
- Centers for Disease Control and Prevention. 10 essential public health services [cited 2022 May 25]. Available from: https://www.cdc.gov/publichealthgateway/publichealthservices/essentialhealthservices.html.
- Valentino LA, Witkop ML, Santaella ME, et al. The National Hemophilia Foundation State of the Science Research Summit initiative: executive summary. Expert Rev Hematol. 2023;16(S1):127–132. DOI: 10.1080/17474086.2023.2181782.
- Valentino LA, Witkop ML, Santaella ME, et al. The National Hemophilia Foundation’s State of the Science Research Summit initiative: the foundation of an inherited bleeding disorders national research blueprint. Expert Rev Hematol. 2023;16(S1):1–5. DOI: 10.1080/17474086.2023.2178412.
- U.S. Department of Health and Human Services. Healthy People 2020: sex-specific objectives [cited 2022 May 5]. Available from: https://www.healthypeople.gov/2020/data-search/Search-the-Data?sex=543.
- U.S. Department of Health and Human Services. Search the data | Healthy People 2020: BDBS-14 (Developmental) Increase the proportion of providers who refer women with symptoms suggestive of inherited bleeding disorders for diagnosis and treatment [cited 2022 May 5]. Available from: https://www.healthypeople.gov/2020/data-search/Search-the-Data?nid=4026.
- U.S. Department of Health and Human Services. Search the data | Healthy People 2020: BDBS-15 Increase the proportion of persons with von Willebrand disease (VWD) seen in specialty care centers who were diagnosed by 21 years of age [cited 2022 May 5]. Available from: https://www.healthypeople.gov/2020/data-search/Search-the-Data?nid=4027.
- U.S. Department of Health and Human Services. Healthy People 2020: Topics & objectives [cited 2022 Sept 24]. Available from: https://wayback.archive-it.org/5774/20220413162703/https://www.healthypeople.gov/2020/topics-objectives.
- Baker JR, Riske B, Voutsis M, et al. Insurance, home therapy, and prophylaxis in U.S. youth with severe hemophilia. Am J Prev Med. 2011;41(6 Suppl 4):S338–45.
- Huynh AK, Hamilton AB, Farmer MM, et al. A pragmatic approach to guide implementation evaluation research: strategy mapping for complex interventions. Front Public Health. 2018;6:134.
- Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38(2):65–76.
- Chen CX, Baker JR, Nichol MB. Economic burden of illness among persons with hemophilia B from HUGS Vb: examining the association of severity and treatment regimens with costs and annual bleed rates. Value Health. 2017;20(8):1074–1082.
- Curtis R, Manco-Johnson M, Konkle BA, et al. Comorbidities, health-related quality of life, health-care utilization in older persons with hemophilia-hematology utilization group study part VII (HUGS VII). J Blood Med. 2022;13:229–241.
- Globe DR, Cunningham WE, Andersen R, et al. Haemophilia utilization group study: assessment of functional health status in haemophilia. Haemophilia. 2002;8(2):121–128.
- Globe DR, Cunningham WE, Andersen R, et al. The hemophilia utilization group study (HUGS): determinants of costs of care in persons with haemophilia A. Haemophilia. 2003;9(3):325–331.
- Niu X, Poon JL, Riske B, et al. Physical activity and health outcomes in persons with haemophilia B. Haemophilia. 2014;20(6):814–821.
- Poon JL, Zhou ZY, Doctor JN, et al. Quality of life in haemophilia A: hemophilia utilization group study va (HUGS-Va). Haemophilia. 2012;18(5):699–707.
- Zhou ZY, Riske B, Forsberg AD, et al. Self-reported barriers to hemophilia care in people with factor VIII deficiency. Am J Prev Med. 2011;41(6 Suppl 4):S346–53.
- Zhou ZY, Wu J, Baker J, et al. Haemophilia utilization group study - Part Va (HUGS Va): design, methods and baseline data. Haemophilia. 2011;17(5):729–736.
- Roberts JC, Kulkarni R, Kouides PA, et al. Depression and anxiety in persons with von Willebrand disease. Blood. 2021;138(Suppl Supplement 1):4052.
- Hematology Utilization Group Study. Research collected from across the U.S. shared all over the world [cited 2022 Sept 25]. Available from: https://hugsresearch.net/research.
- Lanzkron S, Crook N, Wu J, et al. PRO66 Health-Related quality of life in persons with sickle cell disease. Value Health. 2021;24(Suppl 5):S209–S210.
- Chai-Adisaksopha C, Noone D, Curtis R, et al. Non-severe haemophilia: is it benign? - Insights from the PROBE study. Haemophilia. 2021;27(Suppl 1):17–24.
- Chai-Adisaksopha C, Skinner MW, Curtis R, et al. Psychometric properties of the patient reported outcomes, burdens and experiences (PROBE) questionnaire. BMJ Open. 2018;8(8):e021900.
- Chai-Adisaksopha C, Skinner MW, Curtis R, et al. Exploring regional variations in the cross-cultural, international implementation of the Patient reported outcomes burdens and experience (PROBE) study. Haemophilia. 2019;25(3):365–372.
- Chai-Adisaksopha C, Skinner MW, Curtis R, et al. Test-retest properties of the patient reported outcomes, burdens and experiences (PROBE) questionnaire and its constituent domains. Haemophilia. 2019;25(1):75–83.
- Germini F, Borg Debono V, Page D, et al. User-centered development and testing of the online patient-reported outcomes, burdens, and experiences (PROBE) survey and the myPROBE app and integration with the Canadian bleeding disorder registry: mixed methods study. JMIR Hum Factors. 2022;9(1):e30797.
- Germini F, Chai-Adisaksopha C, Pete D, et al. Evaluation of the sexual health in people living with hemophilia. Haemophilia. 2021;27(6):993–1001.
- Hay CRM, Shima M, Makris M, et al. Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company. Haemophilia. 2020;26(6):966–974.
- Skinner MW, Chai-Adisaksopha C, Curtis R, et al. The patient reported outcomes, burdens and experiences (PROBE) project: development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia. Pilot Feasibility Stud. 2018;4:58.
- National Academy of Medicine. The Future of Health Services Research: Advancing Health Systems Research and Practice in the United States. Washington (DC); 2018. [cited 2023 Jan 13]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30640418
- Stonebraker JS, Bolton-Maggs PHB, Brooker M, et al. The World Federation of Hemophilia annual global survey 1999-2018. Haemophilia. 2020;26(4):591–600.
- Health Resources & Services Administration. What is shortage designation? [cited 2022 Sept 25]. Available from: https://bhw.hrsa.gov/workforce-shortage-areas/shortage-designation.
- Centers for Medicare & Medicaid Services. Innovation Center Strategy Refresh [cited 2022 Aug 23]. Available from: https://innovation.cms.gov/strategic-direction-whitepaper.
- Centers for Disease Control and Prevention. CDC Core Health Equity Science and Intervention Strategy [cited 2022 Sept 25]. Available from: https://www.cdc.gov/healthequity/core/index.html.
- McLellan SE, Mann MY, Scott JA, et al. A blueprint for change: guiding principles for a system of services for children and youth with special health care Needs and their families. Pediatrics. 2022;149(Suppl):7.
- Bowleg L. The problem with the phrase women and minorities: intersectionality-an important theoretical framework for public health. Am J Public Health. 2012;102(7):1267–1273.
- Parker M, Hannah M, Zia A. “If I wasn’t a girl”: experiences of adolescent girls with heavy menstrual bleeding and inherited bleeding disorders. Res Pract Thromb Haemost. 2022;6(4):e12727.
- Witkop M, Guelcher C, Forsyth A, et al. Treatment outcomes, quality of life, and impact of hemophilia on young adults (aged 18-30 years) with hemophilia. Am J Hematol. 2015;90(Suppl 2):S3–10.
- Saha S, Beach MC, Cooper LA. Patient centeredness, cultural competence and healthcare quality. J Natl Med Assoc. 2008;100(11):1275–1285.
- Capers Q. How clinicians and educators can mitigate implicit bias in patient care and candidate selection in medical education. ATS Sch. 2020;1(3):211–217.
- American Medical Association Center for Health Equity. Organizational strategic plan to embed racial justice and advance health equity: American medical association; [cited 2022 Aug 23]. Available from: https://www.ama-assn.org/system/files/2021-05/ama-equity-strategic-plan.pdf.
- American Society of Hematology. Message from the ASH president on diversity, equity, and inclusion 2020 [cited 2022 Aug 23]. Available from: https://www.hematology.org/newsroom/press-releases/2020/message-from-the-ash-president-on-diversity-equity-and-inclusion.
- American Public Health Association. Health Equity [cited 2022 Aug 23]. Available from: https://www.apha.org/topics-and-issues/health-equity.
- Haley KM, Sidonio RF Jr., Abraham S, et al. A cross-sectional study of women and girls with congenital bleeding disorders: the American thrombosis and hemostasis network cohort. J Womens Health (Larchmt). 2020;29(5):670–676.
- Byams VR, Miller CH, Bethea FM, et al. Bleeding disorders in women and girls: state of the science and CDC collaborative programs. J Womens Health (Larchmt). 2022;31(3):301–309.
- Centers for Disease Control and Prevention. About Community Counts [cited 2022 Aug 23]. Available from: https://www.cdc.gov/ncbddd/hemophilia/communitycounts/about.html.
- National Institute on Minority Health and Health Disparities. NIMHD Science Visioning Research Strategies [cited 2022 Aug 24]. Available from: https://nimhd.nih.gov/about/overview/science-visioning/visioning-strategies.html#methods.
- Chawla NV, Bowyer KW, Hall LO, et al. SMOTE: synthetic minority over-sampling technique. J artif intell res. 2002;16:321–357.
- Cascino TM, Somanchi S, Colvin M, et al. Racial and sex inequities in the use of and outcomes after left ventricular assist device implantation among medicare beneficiaries. JAMA Network Open. 2022;5(7):e2223080.
- Witt RE, Colvin BN, Lenze SN, et al. Lived experiences of stress of black and Hispanic mothers during hospitalization of preterm infants in neonatal intensive care units. J Perinatol. 2022;42(2):195–201.
- Witt RE, Malcolm M, Colvin BN, etv al. Racism and Quality of Neonatal Intensive Care: Voices of Black Mothers. Pediatrics. 2022;150(3). DOI:10.1542/peds.2022-056971. https://www.ncbi.nlm.nih.gov/pubmed/35965288
- Statler MC, Wall BM, Richardson JW, et al. African American perceptions of participating in health research despite historical mistrust. ANS Adv Nurs Sci. 2022.
- O’Donoghue J, Luther J, Hoque S, et al. Strategies to improve the recruitment and retention of underserved children and families in clinical trials: a case example of a school-supervised asthma therapy pilot. Contemp Clin Trials. 2022;128:106884.
- Lee LH, Whisenton LH, Benger J, et al. A community-centered approach to sickle cell disease and clinical trial participation: an evaluation of perceptions, facilitators, and barriers. Blood Adv. 2021;5(23):5323–5331.
- Ricks JM, Arthur EK, Stryker SD, et al. A systematic literature review of community-based participatory health research with sexual and gender minority communities. Health Equity. 2022;6(1):640–657.
- National Institute on Minority Health and Health Disparities. Community-Based Participatory Research Program (CBPR) [cited 2022 May 19]. Available from: https://www.nimhd.nih.gov/programs/extramural/community-based-participatory.html.
- Winn RA. Diversity in clinical trials award program. Robert A. Winn Diversity in Clinical Trials Award Program [cited 2022 Aug 23]. Available from: https://diversityinclinicaltrials.org/.
- National Medical Fellowships. Programs portfolio overview [cited 2022 Aug 23]. Available from: https://nmfonline.org/scholarships-programs/programs-portfolio-overview/.
- American Society of Hematology. ASH Minority Recruitment Initiative [cited 2022 Aug 23]. Available from: https://www.hematology.org/awards/minority-recruitment.
- National Hemophilia Foundation. Jeanne Marie Lusher diversity fellowship [cited 2022 Aug 23]. Available from: https://www.hemophilia.org/research/fund-your-research/jeanne-marie-lusher-diversity-fellowship.
- Pipe SW, Reddy KR, Chowdary P. Gene therapy: practical aspects of implementation. Haemophilia. 2022;28(Suppl 4):44–52.
- European Medicines Agency. First gene therapy to treat severe haemophilia A [cited 2022 Jul 20]. Available from: https://www.ema.europa.eu/en/news/first-gene-therapy-treat-severe-haemophilia.
- U.S. Food and Drug Administration. FDA approves first gene therapy to treat adults with hemophilia B 2022 [cited 2022 Nov 23]. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treat-adults-hemophilia-b.
- Reiss UM, Mahlangu J, Ohmori T, et al. Haemophilia gene therapy-update on new country initiatives. Haemophilia. 2022;28(Suppl 4):61–67.
- Skivington K, Matthews L, Simpson SA, et al. Framework for the development and evaluation of complex interventions: gap analysis, workshop and consultation-informed update. Health Technol Assess. 2021;25(57):1–132.
- Perez Jolles M, Lengnick-Hall R, Mittman BS. Core Functions and. Forms of complex health interventions: a patient-centered medical home illustration. J Gen Intern Med. 2019;34(6):1032–1038.
- Hawe P, Shiell A, Riley T. Complex interventions: how “out of control” can a randomised controlled trial be? BMJ. 2004;328(7455):1561–1563.
- Hawe P. Lessons from complex interventions to improve health. Annu Rev Public Health. 2015;36:307–323.
- Kerkhoff AD, Farrand E, Marquez C, et al. Addressing health disparities through implementation science-a need to integrate an equity lens from the outset. Implement Sci. 2022;17(1):13.
- Brownson RC, Kumanyika SK, Kreuter MW, et al. Implementation science should give higher priority to health equity. Implement Sci. 2021;16(1):28.
- Lin JL, Huber B, Amir O, et al. Barriers and facilitators to the implementation of family-centered technology in complex care: feasibility study. J Med Internet Res. 2022;24(8):e30902.
- Pew Research Center. Internet/broadband fact sheet [cited 2022 Aug 26]. Available from: https://www.pewresearch.org/internet/fact-sheet/internet-broadband/?menuItem=3109350c-8dba-4b7f-ad52-a3e976ab8c8f.